Officially completing its acquisition of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT), Sun Pharmaceutical Industries Ltd. has ...

Fortress will receive ~$28 million shortly after closing and is eligible for an additional contingent value right (CVR) of up ...

Sun Pharmaceutical Industries plans a USD 100 million investment to commercialize innovative products this fiscal year, ...

The acquisition of Checkpoint Therapeutics by Sun Pharmaceutical ... Fortress aims to further advance its pipeline and focus on new business development opportunities, including potential FDA ...

Checkpoint Therapeutics Inc.'s planned $355 million sale to Sun Pharmaceuticals Inc. will likely siphon value from public ...

Sun Pharma to invest $100 million in speciality products, targeting growth in innovative treatments for the future.

Checkpoint Therapeutics Inc. defeated investor claims it concealed the likelihood US regulators would deny its skin cancer ...

The company projects revenue growth of mid- to high single digits in FY26 compared with an 8.5% increase in FY25 ...

Checkpoint Therapeutics, Inc. (CKPT) (“Checkpoint”), has been acquired by Sun Pharmaceutical Industries Limited (together with its subsidiaries and/or associated companies, “Sun Pharma”).